Tempus AI’s (TEM) Market Perform Rating Reaffirmed at William Blair

William Blair reiterated their market perform rating on shares of Tempus AI (NASDAQ:TEM) in a research note issued to investors on Tuesday,RTT News reports.

TEM has been the subject of a number of other reports. Wolfe Research began coverage on shares of Tempus AI in a research report on Friday, December 13th. They issued an “outperform” rating and a $60.00 price target for the company. Guggenheim reaffirmed a “buy” rating on shares of Tempus AI in a report on Tuesday. Bank of America upped their target price on Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research report on Friday, December 13th. TD Cowen restated a “buy” rating and issued a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Finally, Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and upped their price objective for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, Tempus AI presently has a consensus rating of “Moderate Buy” and an average target price of $60.55.

Tempus AI Price Performance

NASDAQ:TEM opened at $59.10 on Tuesday. Tempus AI has a 52 week low of $22.89 and a 52 week high of $91.45. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The firm’s 50-day simple moving average is $51.28 and its 200 day simple moving average is $52.17.

Insider Activity at Tempus AI

In related news, major shareholder Bradley A. Keywell sold 395,800 shares of the firm’s stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total value of $16,999,610.00. Following the completion of the transaction, the insider now owns 16,164,449 shares in the company, valued at $694,263,084.55. This trade represents a 2.39 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Andrew Polovin sold 51,504 shares of the firm’s stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $42.39, for a total transaction of $2,183,254.56. Following the completion of the transaction, the executive vice president now owns 246,085 shares of the company’s stock, valued at approximately $10,431,543.15. This trade represents a 17.31 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 2,583,467 shares of company stock valued at $130,542,311.

Hedge Funds Weigh In On Tempus AI

Large investors have recently modified their holdings of the business. Operose Advisors LLC bought a new stake in shares of Tempus AI in the fourth quarter worth $25,000. First Horizon Advisors Inc. acquired a new position in Tempus AI during the 3rd quarter worth about $30,000. Farther Finance Advisors LLC acquired a new position in Tempus AI during the 4th quarter worth about $34,000. Prestige Wealth Management Group LLC grew its position in shares of Tempus AI by 910.4% in the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after buying an additional 965 shares during the last quarter. Finally, NewEdge Advisors LLC acquired a new stake in shares of Tempus AI in the fourth quarter valued at about $49,000. Institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.